------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------MAY------------------- 12,---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 2002 DEBATE BEGINS ON SMALLPOX VACCINATION--------------------------------------------------------------------------------------------------------------------------T-----------HE ADVISORY--------------------- COMMITTEE ON IMMUNIZATION PRACTICES IS EXPECTED TO MAKE RECOMMENDATIONS--------------------- IN JUNE ON WHETHER-AMERICANS SHOULD BE VACCINATED AGAINST--------------------- SMALLPOX, A DISEASE THAT NO LONGER EXISTS ON THE PLANET.------------------------THE UNITED STATES AND THE REST OF THE WORLD-HAVE BEEN COMFORTABLE--------------------- FOR MORE THAN TWO DECADES IN THE KNOWLEDGE THAT THE LAST CASE--------------------- OF SMALLPOX OCCURRED IN-----, AND-THE DISEASE WAS DECLARED--------------------- COMPLETELY ERADICATED IN------ AFTER ELIMINATING STOCKS OF--------------------- THE VIRUS IN LABORATORIES WORLDWIDE, THE WORLD HEALTH ORGANIZATION--------------------- WAS ABLE TO SAY IN 1984 THAT THE ONLY REMAINING VARIOLA VIRUS--------------------- ISOLATES ARE STORED AT JUST TWO SITES: THE CENTERS FOR DISEASE--------------------- CONTROL AND PREVENTION IN-ATLANTA AND THE STATE RESEARCH CENTER--------------------- OF VIROLOGY AND-BIOTECHNOLOGY IN-NOVOSIBIRSK, RUSSIA.----------------------- BUT THERE ARE LINGERING CONCERNS THAT THE VIRUS RESIDES--------------------- OUTSIDE THOSE LABORATORIES AND COULD BE USED AS A WEAPON BY--------------------- TERRORISTS. AND THE EFFECTS OF SUCH A TERRORIST ATTACK WOULD--------------------- BE CATASTROPHIC, SAY PUBLIC HEALTH-OFFICIALS, FOR TWO REASONS:--------------------- THE VIRUS IS-HIGHLY CONTAGIOUS AND SPREADS READILY AND RAPIDLY--------------------- FROM PERSON TO PERSON, AND ALMOST NO ONE IN THE UNITED STATES ---------------------IS IMMUNE TO THE INFECTION. SMALLPOX-VACCINATION HAS NOT BEEN--------------------- PERFORMED ROUTINELY-IN THIS COUNTRY SINCE 1972, SO THERE IS----------------------NOW A LARGE POPULATION OF CHILDREN AND YOUNG ADULTS WHO WERE--------------------- NEVER IMMUNIZED. AND-EVEN PERSONS BORN BEFORE 1972, WHO PROBABLY--------------------- RECEIVED A SMALLPOX VACCINATION IN ORDER TO ENTER SCHOOL AND--------------------- HAVE THE SCAR TO PROVE IT, MAY NO LONGER BE IMMUNE, SINCE--------------------- NO ONE KNOWS EXACTLY HOW LONG VACCINATION-INDUCED IMMUNITY--------------------- LASTS.----------------------- THAT MEANS ALMOST EVERYONE IN THE UNITED STATES WOULD POTENTIALLY--------------------- BE AT RISK IF TERRORISTS INTRODUCED THE SMALLPOX VIRUS, EITHER--------------------- BY SENDING INFECTED PERSONS TO MINGLE WITH CROWDS OR BY DISSEMINATING--------------------- THE VIRUS ITSELF IN-THE AIR-OR ON COMMONLY USED OBJECTS. THAT----------------------POSES QUESTIONS FOR THE COMMITTEE ON IMMUNIZATION PRACTICES,----------------------INCLUDING:-------------------------------------------------SHOULD WE ACT NOW TO MAKE SMALLPOX VACCINE AVAILABLE TO----------------------- EVERYONE IN THE UNITED STATES, OR, ALTERNATIVELY, TO YOUNG----------------------- PEOPLE BETWEEN THE-AGES OF ONE YEAR AND 29 WHO WERE NEVER----------------------- VACCINATED; AND SHOULD VACCINATION BE COMPULSORY OR VOLUNTARY?------------------------- OR SHOULD WE WAIT UNTIL THERE-IS AN ATTACK, RELYING ON----------------------- THE FACT THAT IMMUNIZATION WITHIN TWO OR THREE DAYS OF EXPOSURE----------------------- SEEMS TO PREVENT OR LESSEN THE SEVERITY OF-SMALLPOX?---------------------------------------------- A NUMBER OF FACTORS MAY ENTER INTO THE COMMITTEE'S DECISIONS.--------------------- ONE IS WHETHER THERE IS ENOUGH SMALLPOX VACCINE TO CARRY THROUGH--------------------- WHATEVER RECOMMENDATION THE COMMITTEE MAY COME UP WITH. THERE--------------------- IS CURRENTLY A-LIMITED STOCKPILE OF VACCINE IN THIS COUNTRY,--------------------- MOST OF IT PRODUCED IN 198--OR EARLIER.-IN STUDIES PUBLISHED----------------------IN APRIL IN THE--- NEW ENGLAND JOURNAL OF MEDICINE----, RESEARCHERS--------------------- REPORTED THAT THEY FOUND THOSE VACCINES CAN BE DILUTED--------------------- 5- TO 10-FOLD "WITHOUT SUBSTANTIAL LOSS OF EFFICACY." "WHEN ADMINISTERED--------------------- BY A BIFURCATED NEEDLE TO PREVIOUSLY UNVACCINATED ADULTS,--------------------- THE VACCINE PRODUCED VESICULAR SKIN LESIONS THAT CORRELATE--------------------- WITH THE INDUCTION OF THE ANTIBODY AND T-CELL RESPONSES THAT--------------------- ARE CONSIDERED ESSENTIAL-FOR CLEARING VACCINIA VIRUS INFECTIONS.------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------" "THE------------------------- CURRENT STOCKPILE OF--5 MILLION DOSES OF SMALLPOX VACCINE------------------------- MAY SAFELY BE DILUTED TO YIELD AT LEAST 75 MILLION DOSES.-----------------------------------------------------------------------------------------------------------------" -- DR. ANTHONY--------------------------- FAUCI-------------------------------------------------------------------------------------------------------------------------------------------------------------- THAT MEANS, SAYS DR. ANTHONY FAUCI OF THE NATIONAL INSTITUTES--------------------- OF ALLERGY AND INFECTIOUS DISEASES, THAT "THE CURRENT STOCKPILE--------------------- OF 15 MILLION DOSES OF SMALLPOX VACCINE MAY SAFELY BE DILUTED--------------------- TO YIELD AT LEAST 75 MILLION DOSES." IN ADDITION, HE POINTS--------------------- OUT, THE ONGOING PRODUCTION OF SECOND-GENERATION SMALLPOX--------------------- VACCINES WILL INCREASE-OUR SUPPLY-TO APPROXIMATELY 286 MILLION--------------------- DOSES BY THE END OF THIS YEAR, AND THE DEPARTMENT OF HEALTH--------------------- AND HUMAN SERVICES HAS SAID IT WILL-TEST FOR SAFETY AND IMMUNOGENICITY--------------------- SOME 75 MILLION DOSES-OF VACCINE THAT RECENTLY-WERE DISCOVERED--------------------- TO HAVE BEEN-STORED BY A PHARMACEUTICAL COMPANY SINCE--------------------------- "THUS, THE AVAILABILITY OF VACCINE WILL SOON BECOME LESS OF----------------------A FACTOR IN THE FORMULATION OF A POLICY," FAUCI SAID.----------------------- ANOTHER POINT THE ADVISORY COMMITTEE MAY-CONSIDER IS HOW--------------------- IMMUNIZATION ON A MASSIVE SCALE MIGHT-BE HANDLED, EITHER BEFORE ---------------------OR DURING A TERRORIST ATTACK. IN ITS SUCCESSFUL CAMPAIGN TO--------------------- ERADICATE SMALLPOX WORLDWIDE 40 YEARS AGO, THE WORLD HEALTH--------------------- ORGANIZATION-RELIED ON A TECHNIQUE CALLED "RING VACCINATION,---------------------" WHICH IS THE APPROACH CURRENTLY RECOMMENDED IN GUIDELINES--------------------- DEVELOPED BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION.--------------------- IN RING VACCINATION, PATIENTS WITH SUSPECTED OR-CONFIRMED ---------------------SMALLPOX ARE ISOLATED; CONTACTS ARE TRACED, VACCINATED, AND--------------------- KEPT UNDER CLOSE-SURVEILLANCE; AND HIGH-RISK PERSONS WHO MAY----------------------HAVE HAD DIRECT OR INDIRECT CONTACT WITH THE-PATIENT ARE IDENTIFIED--------------------- AND VACCINATED.----------------------- "DESPITE THE FUNDAMENTAL SOUNDNESS OF THIS APPROACH AND--------------------- ITS SUCCESS IN PREVIOUS NATURALLY OCCURRING OUTBREAKS, THERE--------------------- IS CONSIDERABLE SKEPTICISM ABOUT THE FEASIBILITY OF THIS STRATEGY,---------------------" IN THE EVENT OF A TERRORIST ATTACK, FAUCI NOTES, SINCE MULTIPLE--------------------- EXPOSURES AND THE RESULTING PANIC COULD OVERWHELM THE CAPACITY--------------------- OF CDC AND LOCAL AUTHORITIES TO CARRY OUT THE PLAN. AND MOST--------------------- IMPORTANTLY, HE POINTS OUT, PREVIOUS OUTBREAKS THAT WERE CONTROLLED ---------------------BY RING VACCINATION WERE IN THE CONTEXT OF EXISTING HERD IMMUNITY,--------------------- NOT IN AN ESSENTIALLY NON-IMMUNE POPULATION.----------------------- BUT THE-FACTOR THAT SEEMS MOST LIKELY TO AFFECT PUBLIC OPINION----------------------ABOUT THE NEED TO VACCINATE IN ADVANCE OF AN ATTACK, SAYS--------------------- DR. WILLIAM BICKNELL OF THE BOSTON UNIVERSITY SCHOOL OF PUBLIC--------------------- HEALTH, IS THAT SMALLPOX VACCINATION OFTEN HAS ADVERSE REACTIONS--------------------- IN OTHERWISE HEALTHY PERSONS. COMMONLY, RESEARCHERS REPORTED,--------------------- THE HEALTHY YOUNG VOLUNTEERS WHO RECEIVED EITHER FULL-STRENGTH--------------------- OR DILUTE VACCINE TO TEST ITS EFFICACY EXPERIENCED SIDE EFFECTS--------------------- INCLUDING THE FORMATION OF SATELLITE LESIONS, REGIONAL LYMPHADENOPATHY,--------------------- FEVER, HEADACHE, NAUSEA, MUSCLE ACHES, FATIGUE, AND CHILLS,--------------------- AS WELL AS GENERALIZED AND LOCAL RASHES.---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...---------------------- "THERE'S NO OTHER VACCINE THAT WE CURRENTLY- GIVE THAT CARRIES WITH IT A RISK OF DEATH.-----------------------------------------------------------------------------------------------------------------" -- ALEX KEMPER---------------------------------------------------------------------------------------------------------------------------- IN STUDIES REPORTED TO THE PEDIATRIC ACADEMIC SOCIETIES--------------------- ANNUAL MEETING IN BALTIMORE, MARYLAND, MAY 7, PEDIATRICIANS--------------------- ALEX KEMPER AND MATTHEW DAVIS OF THE UNIVERSITY OF MICHIGAN--------------------- PREDICTED THAT A MASS CAMPAIGN TO VACCINATE AMERICANS AGAINST--------------------- SMALLPOX COULD RESULT IN 200 TO 300 DEATHS AND MIGHT MAKE--------------------- SEVERAL THOUSAND PEOPLE SEVERELY ILL WITH COMPLICATIONS SUCH--------------------- AS VIRAL INFECTION SPREADING FROM THE VACCINATION SITE AND--------------------- SEVERE SKIN RASHES. "THERE'S NO OTHER VACCINE THAT WE CURRENTLY--------------------- GIVE THAT CARRIES WITH IT A RISK OF DEATH," KEMPER POINTED--------------------- OUT. "FROM A SOCIETAL VIEWPOINT, WE HAVE TO DECIDE WHETHER--------------------- OR NOT WE'RE WILLING TO TAKE THIS RISK.-----------------------" BUT IN MAKING ITS RECOMMENDATIONS, THE ADVISORY COMMITTEE--------------------- IS EXPECTED TO WEIGH THE VERY SERIOUS NATURE OF SMALLPOX ITSELF--------------------- AGAINST THE POSSIBILITY OF ADVERSE REACTIONS TO IMMUNIZATION--------------------- IN A LIMITED NUMBER OF PEOPLE. MOST DOCTORS AND NURSES NOW--------------------- IN PRACTICE HAVE NEVER SEEN A CASE OF SMALLPOX, BUT A DOCTOR--------------------- WHO TREATED 22 SMALLPOX PATIENTS WHILE STATIONED WITH THE--------------------- MILITARY IN JAPAN IN 1945 DESCRIBED THE EXPERIENCE IN A--- NEW--------------------- ENGLAND JOURNAL OF MEDICINE---- ARTICLE. "THE DISEASE BEGAN--------------------- WITH A HIGH FEVER," DR. MURRAY DWORETZKY RECALLED, "WITH THE--------------------- TEMPERATURE EXCEEDING 40 DEGREES CENTIGRADE AND THEN DROPPING,--------------------- ALTHOUGH NEVER TO NORMAL, BEFORE IT SPIKED AGAIN. ALTHOUGH--------------------- SOME PATIENTS HAD PUSTULAR LESIONS, THOSE WHO DIED HAD CONFLUENT--------------------- SUBCUTANEOUS HEMORRHAGES THAT RAPIDLY INVOLVED THE ENTIRE--------------------- BODY, WITH A SIMILAR ENANTHEMA INVOLVING THE MUCOUS MEMBRANCES--------------------- OF THE ORAL CAVITY, RESPIRATORY MUCOSA, AND ENTIRE GASTROINTESTINAL--------------------- TRACT. THE PAIN WAS-INTENSE AND MORPHINE RELIEVED IT-ONLY--------------------- MARGINALLY." FOURTEEN OF THE 22 PATIENTS DIED.----------------------- ANOTHER--- NEW ENGLAND JOURNAL---- ARTICLE NOTES THAT THE--------------------- INCUBATION PERIOD FOR THE DISEASE IS 7 TO 17 DAYS, AFTER WHICH--------------------- SEVERE BACKACHE, HEADACHE, AND FEVER BEGIN ABRUPTLY. LESIONS----------------------OCCUR FIRST ON THE FACE AND EXTREMITIES BUT THEN COVER THE--------------------- ENTIRE BODY. AFTER SEVERE-SMALLPOX, POCKMARKS OR PITTED LESIONS--------------------- ARE SEEN IN 65 TO 80 PERCENT OF SURVIVORS, MOST COMMONLY ON--------------------- THE FACE. DEATH FROM-SMALLPOX IS ASCRIBED-TO TOXEMIA, ASSOCIATED--------------------- WITH IMMUNE COMPLEXES,-AND TO HYPOTENSION.----------------------- IN ANY CASE, THE--- NEW ENGLAND JOURNAL OF MEDICINE------------------------- EDITORIALIZES, -THE DEBATE ON PREEMPTIVE VACCINATION CANNOT--------------------- GO ON INDEFINITELY. WE NEED TO MAKE A DECISION. IF WE DO PROCEED--------------------- WITH LARGE-SCALE VACCINATION, WE NEED TO CONSIDER WHAT OPERATIONAL--------------------- PLANS MIGHT BE WORKABLE, WHO SHOULD BE IMMUNIZED, WHEN THEY--------------------- SHOULD BE IMMUNIZED, AND HOW TO REDUCE UNINTENDED SEQUELAE.--------------------------" THE COMPLETE TEXT OF THE NEW ENGLAND JOURNAL OF MEDICINE'S--------------------- DISCUSSION OF SMALLPOX AND BIOTERRORISM IS AVAILABLE AT------------------------------------------------------------------------------- HTTP://CONTENT.NEJM.ORG/CONTENT/VOL346/ISSUE17/INDEX.SHTML?QUERY=TOC------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------